{"id":"NCT02525133","sponsor":"Innocoll","briefTitle":"Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty","officialTitle":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of the XaraColl® Bupivacaine Implant (300 mg Bupivacaine Hydrochloride) After Open Laparotomy Hernioplasty","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-09-05","primaryCompletion":"2016-04-22","completion":"2016-04-22","firstPosted":"2015-08-17","resultsPosted":"2021-01-08","lastUpdate":"2021-01-08"},"enrollment":319,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Pain, Postoperative"],"interventions":[{"type":"DRUG","name":"XaraColl","otherNames":["Bupivacaine collagen implant"]},{"type":"OTHER","name":"Placebo","otherNames":["Collagen implant"]}],"arms":[{"label":"XaraColl","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a Phase 3, multicenter, randomized, double-blind, parallel-group, placebo-controlled efficacy and safety study of postoperative pain in adults who are scheduled for unilateral inguinal hernioplasty via open laparotomy (tension-free technique).\n\nPatients will assess their postoperative pain intensity (PI) using an 11-point numerical rating scale (NRS) from 0 hour through 72 hours postoperatively.\n\nThe expected maximum study duration for each patient will be up to 60 days, including a maximum 30-day screening period, the day of surgery and implantation, and a 30-day post implantation period including treatment and follow-up.","primaryOutcome":{"measure":"SPI24","timeFrame":"0 to 24 hours","effectByArm":[{"arm":"XaraColl","deltaMin":88.3,"sd":47.01},{"arm":"Placebo","deltaMin":116.2,"sd":44.04}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":16},"locations":{"siteCount":24,"countries":["United States"]},"refs":{"pmids":["30467808"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":208},"commonTop":["Dizziness","Somnolence","Constipation","Nausea","Incision site pain"]}}